FORM Stock Charts

Quarterly

Annual

Unit: USD	2025-09-27	2025-06-28	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-09-24	2022-06-25	2022-03-26	2021-12-25	2021-09-25	2021-06-26	2021-03-27	2020-12-26	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-09-24	2016-06-25	2016-03-26	2015-12-26	2015-09-26	2015-06-27	2015-03-28	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-09-24	2011-06-25	2011-03-26	2010-06-26	2010-03-27	2009-09-26	2009-06-27	2009-03-28	2008-09-27	2008-06-28	2008-03-29	2007-09-29	2007-06-30	2007-03-31	2006-09-30	2006-07-01	2006-04-01	2005-12-31	2005-09-24	2005-06-25	2005-03-26	2004-12-28	2004-09-27	2004-06-28	2004-03-29	2003-12-29	2003-09-28

cash flows from operating activities:
net income	15,656,000	9,086,000	6,401,000	9,705,000	18,736,000	19,392,000	21,781,000	75,846,000	4,371,000	828,000	1,342,000	-13,727,000	4,351,000	30,242,000	29,872,000	25,897,000	20,497,000	17,905,000	19,625,000	19,273,000	22,891,000	20,469,000	15,890,000	18,636,000	8,279,000	6,948,000	5,483,000	85,100,000	7,688,000	9,123,000	2,125,000	5,588,000	12,563,000	17,577,000	5,185,000	-15,444,000	-14,197,000	36,884,000	-13,800,000	-619,000	-2,525,000	838,000	783,000	-1,871,000	-277,000	-4,326,000	-12,711,000	-18,789,000	-10,714,000	-8,407,000	-19,773,000	603,000	-14,478,000	-4,217,000	-17,454,000	-26,975,000	-9,904,000	-7,678,000	-21,424,000	-33,864,000	-38,184,000	-23,901,000	-65,846,000	-37,943,000	-14,041,000	-18,659,000	-17,961,000	25,057,000	18,650,000	14,832,000	15,819,000	15,281,000	10,768,000	10,481,000	9,778,000	5,012,000	4,911,000	5,822,000	7,497,000	6,683,000	5,176,000	4,068,000	2,505,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization																																				13,224,000	23,164,000	5,171,000	5,239,000	5,896,000	5,967,000	6,024,000	5,884,000	6,336,000	7,970,000	8,054,000	8,131,000	7,055,000	7,282,000	7,165,000	7,407,000	8,905,000	2,577,000	2,576,000	2,843,000	2,245,000	2,775,000	2,883,000	2,935,000	8,222,000	8,662,000	8,215,000	7,876,000	8,113,000	8,287,000	7,949,000	7,827,000	6,954,000	6,470,000	6,146,000	5,483,000	5,753,000	4,683,000	4,329,000	4,420,000	4,363,000	3,401,000		1,670,000
reduction in the carrying amount of right-of-use assets	1,635,000	1,790,000	1,803,000	1,674,000	1,934,000	1,780,000	1,415,000	1,833,000	1,642,000	2,224,000	1,690,000	2,253,000	1,486,000	1,922,000	2,492,000	1,760,000	1,760,000	1,841,000	1,811,000	1,661,000	1,875,000	908,000	1,511,000
stock-based compensation expense	9,516,000	9,391,000	9,796,000	10,213,000	8,936,000	10,209,000	10,405,000	9,283,000	10,839,000	9,204,000	9,290,000	9,464,000	7,995,000	6,358,000	7,520,000	7,799,000	7,920,000	6,588,000	7,077,000	7,056,000	5,509,000	5,642,000	5,623,000	6,088,000	6,504,000	5,289,000	5,295,000	5,406,000	4,537,000	4,128,000	3,756,000	5,060,000	4,587,000	3,390,000	3,302,000	3,245,000	3,202,000	1,541,000	2,734,000	3,060,000	3,100,000	2,506,000	2,909,000	3,256,000	3,934,000	3,519,000	2,570,000	2,999,000	2,958,000	3,132,000	3,035,000	3,560,000	2,968,000	3,478,000	3,043,000	4,188,000	3,340,000	2,352,000	3,969,000	3,894,000	5,258,000	4,503,000	7,122,000	4,787,000	5,094,000	6,694,000	6,117,000	5,857,000	6,424,000	7,679,000	5,976,000	4,667,000	4,372,000	570,000	1,505,000	752,000	754,000		609,000
deferred income tax benefit	6,490,000	-1,948,000	-691,000	689,000	-3,863,000	-8,888,000	-1,293,000		-2,644,000														-198,000													-1,271,000	112,000								2,000
benefit from excess and obsolete inventories	3,227,000	3,816,000	2,879,000	2,290,000	3,775,000	3,131,000	3,146,000	2,437,000	3,938,000	3,655,000	4,973,000	8,554,000	11,352,000	2,225,000	2,501,000	3,923,000	4,723,000	3,504,000	3,394,000	3,354,000	3,356,000	3,120,000	3,287,000	2,375,000	2,742,000	2,579,000	2,725,000	3,065,000	2,821,000	2,548,000	2,045,000	2,360,000	2,302,000	1,800,000	2,797,000	2,194,000	1,637,000	811,000	1,989,000	1,607,000	1,922,000	1,501,000	1,463,000	1,597,000	1,700,000	1,224,000	2,606,000	2,632,000	2,950,000	2,178,000	2,701,000		1,847,000	1,086,000	1,416,000	3,030,000	1,343,000	1,257,000	2,267,000	-688,000	1,200,000	-179,000	756,000	5,062,000	461,000	6,373,000	5,473,000	3,761,000	3,054,000	2,725,000	3,138,000	2,651,000	3,433,000	2,773,000	3,229,000	2,064,000	2,792,000		1,122,000
non-cash restructuring charges	-41,000	58,000	2,102,000									-510,000	0	560,000	150,000	54,000
gain on sale of business and assets	0
income from equity investment	-1,168,000
other adjustments to reconcile net income to net cash from operating activities	685,000	-432,000	-1,024,000		-2,522,000	168,000	176,000		-426,000	1,668,000	133,000		3,923,000	-599,000	32,000		416,000	-929,000	2,140,000		-2,304,000
changes in assets and liabilities:
accounts receivable	-18,502,000	-15,863,000	6,293,000	11,379,000	-2,467,000	-17,299,000	6,466,000	-15,508,000	-966,000	9,096,000	-15,926,000	24,374,000	-3,876,000	4,564,000	966,000	-10,243,000	2,351,000	-4,770,000	3,576,000	-9,257,000	-5,652,000	3,561,000	7,803,000	-10,099,000	-13,597,000	10,372,000	13,805,000	-6,261,000	-4,239,000	-6,684,000	3,354,000	6,446,000	3,902,000	-12,111,000	-8,888,000	6,116,000	8,694,000	-22,917,000	1,260,000	-66,000	7,250,000	-3,095,000	4,172,000	1,969,000	-6,285,000	-4,852,000	-6,781,000	15,892,000	-7,327,000	-5,861,000	-4,806,000	9,373,000	10,922,000	-6,394,000	-8,743,000	16,350,000	-612,000	-4,273,000	5,338,000					4,020,000	5,451,000	11,656,000	12,282,000							-8,519,000	-2,072,000	-4,587,000	-3,788,000		527,000
inventories	-1,545,000	-2,171,000	-10,196,000	-686,000	6,896,000	-9,543,000	-4,926,000	-578,000	-3,030,000	-7,255,000	1,375,000	4,243,000	-755,000	-15,188,000	-17,080,000	-1,320,000	-9,947,000	-10,477,000	-9,911,000	-3,625,000	-7,477,000	-12,017,000	928,000	2,951,000	-5,672,000	-2,916,000	-8,658,000	508,000	-8,119,000	-6,279,000	-7,408,000	-1,365,000	-5,423,000	-5,502,000	-3,345,000	-3,000,000	-755,000	-2,228,000	-5,750,000	-1,830,000	-4,674,000	-1,178,000	-485,000	-1,250,000	-5,555,000	-1,954,000	-3,216,000	-1,233,000	811,000	-3,777,000	-3,781,000	5,279,000	-1,390,000	-1,441,000	-3,374,000																			-6,760,000	-4,877,000	-4,479,000	-1,914,000		-1,568,000
prepaid expenses and other current assets	1,190,000	-1,923,000	-3,794,000	802,000	-2,350,000	870,000	1,224,000	-1,296,000	-662,000	-2,108,000	1,009,000	-2,575,000	-3,311,000	1,439,000	-144,000	177,000	452,000	168,000	3,011,000	-588,000	-2,348,000	-3,031,000	-240,000	4,739,000	-3,637,000	-3,039,000	2,167,000	2,136,000	2,886,000	-4,513,000	-247,000	-270,000	-314,000	-1,614,000	3,068,000	-1,982,000	-2,536,000	-882,000	2,108,000	30,000	960,000	-1,565,000	748,000	265,000	-651,000	-108,000	-328,000	1,700,000	-1,637,000	3,202,000	292,000	43,000	894,000	-196,000	80,000		-2,144,000	2,089,000	2,579,000						-1,401,000	-846,000	2,757,000										-1,649,000
other assets	-529,000	-9,000	469,000	-10,000	281,000	-3,000	17,000	-950,000	887,000	-28,000	-55,000	183,000	-77,000	33,000	-73,000	7,000	11,000	-294,000	-50,000	-40,000	-29,000	54,000	194,000	154,000	-23,000	-8,000	-564,000	10,000	34,000	1,000	662,000	-762,000	97,000	111,000	615,000	8,000	30,000	0	-286,000	0	-9,000	-54,000	313,000	9,000				-299,000	-16,000	-9,000	462,000	101,000				11,000	841,000	522,000	533,000			-15,000	6,000	6,383,000	606,000	114,000	110,000											-81,000				72,000	1,000
accounts payable	-3,950,000	-886,000	10,535,000	545,000	-11,097,000	-2,631,000	4,948,000	845,000	-3,104,000	5,397,000	-1,819,000	-13,714,000	10,092,000	-2,629,000	10,150,000	-8,077,000	3,516,000	-7,750,000	5,722,000	-1,266,000	12,807,000	4,484,000	763,000	-10,101,000	21,189,000	-3,967,000	-7,148,000	-7,375,000	4,186,000	3,251,000	2,988,000	-2,299,000	-4,282,000	102,000	7,220,000	-7,448,000	-10,296,000	12,353,000	8,824,000	-3,278,000	191,000	5,998,000	-4,947,000	-1,843,000	3,598,000	1,782,000	618,000	-13,064,000	5,616,000	1,526,000	3,598,000	-7,354,000	-6,329,000	2,448,000	5,332,000	-8,327,000	1,806,000	-298,000	1,754,000	1,103,000	89,000							-2,013,000	1,412,000	8,213,000	2,023,000			6,456,000	814,000	531,000	-5,483,000		-1,309,000
accrued liabilities	3,413,000	3,517,000	-7,926,000	-3,693,000	-2,876,000	12,207,000	-1,963,000	2,844,000	5,338,000	-397,000	-10,209,000	-2,967,000	-9,137,000	7,222,000	-3,120,000	6,226,000	-6,716,000	12,497,000	-12,732,000	9,138,000	3,225,000	8,499,000	-6,970,000	8,373,000	-547,000	5,966,000	-6,275,000	3,164,000	-5,341,000	5,980,000	-9,521,000	1,858,000	-3,346,000	7,078,000	-4,780,000	1,278,000	-9,085,000	12,190,000	-3,597,000	2,573,000	-1,266,000	2,646,000	-4,286,000	2,281,000	1,984,000	3,288,000	212,000	-1,352,000	1,440,000	415,000	-2,977,000	-4,703,000	1,275,000	1,951,000	354,000																6,016,000	7,976,000	2,861,000	8,094,000	1,857,000	5,437,000	-1,718,000		1,738,000
other liabilities	-1,891,000	1,775,000	712,000	503,000	2,015,000	6,231,000	1,085,000	4,193,000	11,000	137,000	319,000	-339,000	203,000	-14,000	87,000	238,000	-137,000	70,000	114,000	90,000	-20,000	259,000	33,000	-2,208,000	2,333,000	8,000	33,000
deferred revenues	5,055,000	1,753,000	-620,000	-5,184,000	2,943,000	441,000	4,499,000	2,739,000	-2,970,000	-3,899,000	-6,046,000	-2,490,000	1,049,000	-1,181,000	3,908,000	-26,000	478,000	3,933,000	-2,411,000	5,095,000	-49,000	3,978,000	-123,000	-495,000	1,409,000	285,000	1,931,000	247,000	-249,000	472,000	-444,000	-1,547,000	-2,854,000	2,861,000	1,510,000	253,000	66,000	-116,000	-486,000	-323,000	-1,551,000	-197,000	-342,000	838,000	-1,773,000	-154,000	363,000	94,000	823,000	-279,000	376,000	-231,000	-139,000	783,000	651,000	-1,162,000			136,000		701,000	229,000	865,000	3,956,000
operating lease liabilities	-2,021,000	-2,002,000	-2,030,000	-1,975,000	-1,884,000	-1,887,000	-1,530,000	-1,861,000	-1,689,000	-2,344,000	-1,721,000	-2,190,000	-1,564,000	-1,827,000	-2,435,000	-1,788,000	-1,674,000	-2,035,000	-1,945,000	-1,819,000	-1,734,000	-1,171,000	-1,591,000	-1,340,000	-1,244,000	-726,000	-1,690,000
net cash from operating activities	26,991,000	18,893,000	23,539,000	35,913,000	26,731,000	21,878,000	33,012,000	9,250,000	20,571,000	22,472,000	12,309,000	20,738,000	24,247,000	42,646,000	44,155,000	38,927,000	34,282,000	33,799,000	32,356,000	45,047,000	41,762,000	43,108,000	39,339,000	37,670,000	28,002,000	34,738,000	20,638,000	22,562,000	16,080,000	20,736,000	9,322,000	26,455,000	17,587,000	24,478,000	17,803,000	14,935,000	6,078,000	-558,000	-3,032,000	6,921,000	7,531,000	14,281,000	7,389,000	12,244,000	5,936,000	6,355,000	-6,876,000	-3,248,000	3,041,000	4,072,000	-9,667,000	-10,708,000	-696,000	136,000	-14,960,000													1,998,000	33,967,000	6,036,000	17,508,000	33,845,000	7,490,000	15,631,000	11,494,000	12,566,000	-1,942,000		9,337,000
capex	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	767,000	158,000	2,116,000	0	3,559,000	-1,244,000	-1,253,000	0	3,742,000	381,000	601,000	0	0	0	0	0	0	0	1,166,000	623,000	-304,000	-736,000	778,000	0	0	0	0	0	0	0	-33,000	1,502,000	496,000	273,000	-56,000													6,988,000	-1,471,000	1,613,000	0	-344,000	2,212,000	-7,043,000	-9,155,000	-11,368,000	2,220,000		-2,729,000
free cash flows	26,991,000	18,893,000	23,539,000	35,913,000	26,731,000	21,878,000	33,012,000	9,250,000	20,571,000	22,472,000	12,309,000	20,738,000	24,247,000	42,646,000	44,155,000	38,927,000	34,282,000	33,799,000	32,356,000	45,047,000	42,529,000	43,266,000	41,455,000	37,670,000	31,561,000	33,494,000	19,385,000	22,562,000	19,822,000	21,117,000	9,923,000	26,455,000	17,587,000	24,478,000	17,803,000	14,935,000	6,078,000	-558,000	-1,866,000	7,544,000	7,227,000	13,545,000	8,167,000	12,244,000	5,936,000	6,355,000	-6,876,000	-3,248,000	3,041,000	4,072,000	-9,700,000	-9,206,000	-200,000	409,000	-15,016,000													8,986,000	32,496,000	7,649,000	17,508,000	33,501,000	9,702,000	8,588,000	2,339,000	1,198,000	278,000		6,608,000
cash flows from investing activities:
acquisition of property, plant and equipment	-7,505,000	-66,256,000	-18,584,000	-7,663,000	-8,939,000	-8,398,000	-13,436,000	-9,933,000	-5,917,000	-20,476,000	-19,701,000	-26,230,000	-8,908,000	-14,510,000	-15,606,000	-15,143,000	-20,031,000	-17,852,000	-13,470,000	-13,978,000	-5,144,000	-24,693,000	-12,050,000	-6,605,000	-2,782,000	-5,432,000	-6,028,000	-7,543,000	-3,781,000	-4,714,000	-3,831,000	-3,838,000	-6,159,000	-4,294,000	-3,465,000	-3,304,000	-4,584,000	-2,522,000	-1,111,000	-1,996,000	-2,399,000	-2,802,000	-1,443,000	-1,131,000	-1,545,000	-1,356,000	-1,638,000	-1,167,000	-2,292,000	-2,346,000	-2,725,000	-1,830,000	-2,194,000	-2,124,000	-1,804,000
proceeds from sale of business and assets	0
purchase of equity investment	0	0	-67,156,000
purchases of marketable securities	-21,555,000	-47,493,000	-26,330,000	-29,364,000	-31,203,000	-41,052,000	-37,472,000	-38,549,000	-30,263,000	-39,339,000	-27,311,000	-21,645,000	-27,905,000	-28,882,000	-23,462,000	-35,081,000	-43,712,000	-30,124,000	-41,062,000	-21,503,000	-9,995,000	-3,285,000	-16,441,000	-16,725,000	-38,826,000	-8,394,000	-12,382,000	-11,582,000	-8,269,000	-7,128,000	-3,587,000	-23,360,000	-12,683,000			0	0	-3,996,000	-6,591,000	-24,981,000	-17,492,000	-9,509,000	-14,252,000	0	0	0	-31,693,000	-22,127,000	-18,158,000	-33,883,000	-17,170,000	0	-12,506,000	-22,118,000	-47,813,000
purchase of promissory note receivable				0								0	0
proceeds from maturities and sales of marketable securities	35,778,000	35,093,000	27,410,000	29,699,000	25,450,000	43,000,000	25,813,000		34,650,000	24,890,000	33,473,000		26,140,000	27,480,000	17,990,000		28,580,000	28,085,000	14,610,000		14,920,000	12,401,000	23,009,000																																											78,558,000	222,583,000	30,773,000	45,094,000	42,624,000
net cash from investing activities	6,718,000	-78,553,000	-84,660,000	-7,328,000	-16,192,000	-6,140,000	-3,820,000	79,043,000	-1,530,000	-34,925,000	-13,539,000	-23,691,000	-10,902,000	-20,033,000	-21,078,000	-29,765,000	-35,163,000	-19,891,000	-39,922,000	-42,727,000	-35,218,000	-15,535,000	-5,442,000	-26,305,000	-27,577,000	-3,138,000	-9,332,000	-7,832,000	-6,501,000	-3,571,000	-3,391,000	-21,881,000	-15,824,000	-18,638,000	-3,330,000	-3,957,000	-6,894,000	-200,474,000	5,007,000	-1,718,000	-1,182,000	1,194,000	2,835,000	14,343,000	13,354,000	14,271,000	-4,629,000	3,710,000	-1,937,000	-23,995,000	14,472,000	-77,982,000	16,640,000	9,758,000	10,883,000	14,403,000	17,026,000	21,993,000	7,290,000						3,693,000	29,089,000	87,712,000							-10,059,000	-12,819,000	-18,027,000	-13,054,000	47,132,000	-19,624,000
cash flows from financing activities:
proceeds from issuances of common stock	4,543,000	0	21,576,000	0	4,800,000	0	4,948,000	0	3,798,000	0	5,024,000	0	4,812,000	0	5,687,000	6,000	4,738,000	422,000	5,487,000	422,000	4,653,000	422,000	4,513,000	421,000	3,802,000	0	3,870,000	0	2,958,000	0	4,754,000	402,000	4,623,000	7,048,000	7,437,000	1,740,000	2,044,000	0	1,961,000	0	1,615,000	109,000	1,694,000	0	1,387,000	1,000	1,425,000																	1,791,000
purchase of common stock through stock repurchase program, including excise tax paid	-1,658,000
tax withholdings related to net share settlements of equity awards	-4,990,000	-1,487,000	-2,132,000	-1,993,000	-14,421,000	-1,729,000	-1,840,000	-1,338,000	-8,893,000	-69,000	-387,000	-141,000	-11,321,000	-4,171,000	-72,000	-7,961,000	-7,382,000	-4,120,000	-1,141,000	-68,000	-11,582,000	-3,415,000	-385,000	-127,000	-5,741,000	-1,855,000	-302,000	-97,000	-3,241,000	-2,096,000	-357,000	-268,000	-2,156,000	-3,981,000	-480,000
payments on term loan	-277,000	-276,000	-273,000	-272,000	-269,000	-268,000	-266,000
net cash from financing activities	-2,382,000	-4,214,000	-2,964,000	-18,356,000	-26,830,000	-4,934,000	-14,492,000	-21,403,000	-5,357,000			-10,968,000	-27,701,000	-51,247,000	-6,016,000	-10,330,000	-4,953,000	-28,148,000	-3,768,000	-1,965,000	-21,705,000	1,806,000	-9,071,000	12,398,000	-1,939,000	-13,105,000	-3,932,000	-7,597,000	-12,783,000	-14,596,000	-4,353,000	-16,623,000	-7,114,000	-13,082,000	-2,651,000	-7,010,000	169,000	148,494,000	1,961,000	-1,214,000	-1,873,000	-3,399,000	1,694,000	0	1,387,000	-139,000	1,294,000	-130,000	1,139,000	-10,000	1,000,000	-114,000	1,074,000	-3,000	1,182,000					-14,000	1,550,000	4,625,000	1,196,000	1,806,000	2,364,000	301,000	3,279,000	14,810,000	4,106,000	21,476,000	17,352,000	6,093,000	191,292,000	1,829,000	6,100,000	1,377,000	3,085,000		3,210,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-1,121,000	1,478,000	180,000	-3,512,000	2,829,000	-1,234,000	-1,592,000	675,000	-1,366,000	-1,682,000	-276,000	3,198,000	-2,238,000	-2,328,000	-1,142,000	-964,000	-658,000	-102,000	-1,456,000	2,500,000	679,000	271,000	312,000	-566,000	-440,000	486,000	-207,000	260,000	-458,000	-1,136,000	1,078,000
net increase in cash, cash equivalents and restricted cash	30,206,000	-62,396,000	-63,905,000	6,717,000	-13,462,000	9,570,000	13,108,000	67,565,000			2,872,000				15,919,000	-2,132,000	-6,492,000	-14,342,000	-12,790,000	2,855,000	-14,482,000	29,650,000	25,138,000	23,197,000	-1,954,000	18,981,000	7,167,000	7,393,000	-3,662,000	1,433,000	2,656,000
cash, cash equivalents and restricted cash, beginning of year	0	0	197,206,000	0	0
cash, cash equivalents and restricted cash, end of period	30,206,000	-62,396,000	133,301,000				194,381,000		12,318,000	-14,464,000	115,854,000		-16,594,000	-30,962,000	171,261,000		-6,492,000	-14,342,000	178,308,000		-14,482,000	29,650,000	173,075,000		-1,954,000	18,981,000	107,713,000		-3,662,000	1,433,000	95,382,000
depreciation		8,895,000	8,156,000	8,124,000	7,634,000	7,370,000	7,193,000	7,723,000	7,759,000	7,545,000	7,576,000	7,457,000	7,043,000	7,186,000	6,960,000	6,516,000	6,578,000	6,548,000	6,130,000	6,203,000	5,251,000	4,679,000	4,561,000	4,541,000	4,355,000	4,342,000	3,947,000	3,820,000	3,601,000	3,368,000	3,525,000	3,580,000	3,497,000	3,387,000	3,162,000
amortization		665,000	674,000	662,000	640,000	640,000	640,000	807,000	1,277,000	2,388,000	2,378,000	2,335,000	2,354,000	2,333,000	2,369,000	2,385,000	2,462,000	7,095,000	6,805,000	7,742,000	6,532,000	6,454,000	7,263,000	7,424,000	6,079,000	7,079,000	7,090,000	7,497,000	7,512,000	7,170,000	7,194,000	7,431,000	7,515,000	7,645,000	8,349,000
gain on sale of business				0	0	-310,000	-20,271,000
proceeds from sale of business				0	0	310,000	21,275,000
purchase of common stock through stock repurchase program			-22,135,000	-16,091,000	-16,940,000	-2,937,000	-17,334,000					-8,850,000	-19,150,000	-44,931,000	-9,397,000	-87,000	0	-18,213,000	-5,738,000
amortization (accretion) of discount on investments																								-74,000	-111,000	-109,000	-71,000
acquired inventory step-up amortization																																85,000	5,000	289,000	190,000	2,986,000
loss on disposal of long-lived assets																							204,000	159,000	65,000	144,000	118,000	61,000	216,000	33,000	15,000
foreign currency transaction losses																											121,000	-284,000																1,609,000				396,000	53,000
other than temporary impairment on debt receivable
deferred grant								0	0	0	18,000,000
acquisition of business, net of cash acquired																				-16,881,000
cash, cash equivalents and restricted cash, end of year
the accompanying notes are an integral part of these consolidated financial statements.
cash, cash equivalents and restricted cash, beginning of period							181,273,000		0	0	112,982,000		0	0	155,342,000		0	0	191,098,000		0	0	147,937,000		0	0	100,546,000		0	0	92,726,000
deferred income tax provision																								4,916,000	0				0	11,000	59,000		18,000	23,000	81,000						0							299,000	0	17,000	129,000		17,000									3,310,000
gain on contingent consideration																0	0			892,000	-71,000
proceeds from maturities of marketable securities																										10,660,000	9,050,000	11,266,000	5,500,000	8,250,000	4,007,000	5,996,000				0	10,600,000	21,200,000	12,700,000	25,250,000	17,500,000	13,500,000	18,500,000	15,150,000	14,048,000	15,600,000	28,675,000	26,915,000	18,500,000	10,500,000	34,470,000	20,500,000	20,340,000	34,000,000	60,500,000	75,701,000	88,815,000	83,500,000	60,665,000	101,454,000	53,771,000	110,569,000	95,915,000	53,515,000								95,391,000	48,383,000		78,831,000	16,913,000	11,166,000		48,465,000
payment of contingent consideration																0	0
acquisition of business													-229,000
principal repayments on term loans									-262,000	-260,000	-259,000		-2,042,000	-2,145,000	-2,234,000		-2,309,000	-2,364,000	-2,376,000		-14,776,000	-13,123,000	-13,199,000
net decrease in cash, cash equivalents and restricted cash													-16,594,000
net cash from (used) in financing activities											4,378,000
loss on derivative instruments																							676,000		98,000	-25,000	59,000
proceeds from sale of subsidiary																																20,000	19,000	15,000	14,000	14,000	14,000	10,000	9,000		9,000	5,000	30,000				27,000
proceeds from term loan
payment of term loan issuance costs
amortization of debt issuance costs																							19,000	28,000	36,000	45,000	51,000	57,000	98,000	112,000	123,000	137,000	148,000	163,000	171,000	191,000
proceeds from sale of a subsidiary																					0	42,000	40,000		37,000	28,000	28,000		26,000	21,000	20,000
payment of term loan debt issuance costs																					0
proceeds from term loan debt																					0															0	0
accretion of discount on investments																							-28,000						-15,000	13,000	23,000		13,000				-3,000	-12,000	-16,000
proceeds from sale of property and property, plant and equipment
non-cash investing and financing activities:
change in accounts payable and accrued liabilities related to property, plant and equipment purchases																					767,000	158,000	2,116,000		3,559,000	-1,244,000	-1,253,000		3,742,000	381,000	601,000
operating lease, right-of-use assets obtained in exchange for lease obligations																					1,121,000	-5,879,000	6,307,000		415,000	172,000	35,713,000
supplemental disclosure of cash flow information:
cash paid for income taxes																					3,342,000	1,714,000	2,419,000		1,175,000	618,000	1,082,000		1,331,000	411,000	771,000
cash paid for interest																					210,000	182,000	291,000		350,000	476,000	302,000		682,000	791,000	826,000
foreign currency transaction gains																							-266,000		237,000					452,000	-561,000	238,000	-514,000	-712,000	-729,000				-1,393,000				-192,000
benefit for doubtful accounts receivable																																										2,000	-13,000						0
gain on derivative instruments																																8,000	6,000	41,000	-65,000
acquisition of frt gmbh, net of cash acquired
purchase and retirement of common stock																																-8,007,000	-831,000	-7,399,000	-2,733,000					-1,214,000	-3,488,000								0	-2,000	-3,000
amortization of operating lease, right-of-use assets																									1,301,000	1,343,000	1,277,000
refundable income taxes																									45,000	738,000	-1,000	9,000	8,000	977,000	-52,000	27,000	-743,000	17,000	286,000	0				0	0	0	782,000					10,000	776,000	3,846,000	511,000	-879,000	0	897,000	-45,000					-109,000	26,458,000	-3,101,000	-4,238,000	18,921,000
proceeds from sale of property, plant and equipment																																					0							294,000
principal repayments on term loan																									0	-11,250,000	-7,500,000		-12,500,000	-12,500,000	-8,750,000
income tax payable																										896,000	943,000		33,000	548,000	-829,000		455,000	-133,000	-419,000		-1,552,000	1,000	-2,000		117,000	-102,000	21,000		20,000	-195,000	335,000																							8,220,000
impairment of long-lived assets																																								0	0			390,000	86,000	0	743,000	567,000	15,000	121,000	58,000	49,000	143,000	61,000	168,000	98,000	100,000	0	351,000
income taxes payable																																																		154,000	61,000	-766,000	158,000	-1,615,000	78,000													-3,387,000
deferred rent and other liabilities																												664,000	-95,000	25,000	2,515,000	10,000	4,000	26,000	71,000	-167,000	178,000	-63,000	178,000	-27,000	-69,000	74,000	74,000	97,000	39,000	78,000	34,000	30,000	22,000	24,000	7,000	43,000	39,000	39,000	46,000
acquisition of cascade microtech, net of cash acquired																																				0	-12,815,000
recovery of doubtful accounts receivable																																						0	-34,000
(gain) loss on derivative instruments
gain on disposal off of long-lived assets
change in restricted cash																																-699,000	-1,000	331,000	121,000	-667,000	-109,000											0	-15,000	0	-103,000					-20,000
payments on term loan debt																																-8,750,000	-8,750,000	-8,750,000	-6,875,000	-8,750,000
effect of exchange rate changes on cash and cash equivalents																																150,000	617,000	622,000	1,207,000	-2,468,000	330,000	850,000	1,713,000	90,000	621,000	-981,000	135,000	-1,911,000	-1,272,000	173,000	214,000	-606,000	67,000	-288,000	-667,000	-1,015,000	221,000	-604,000	-618,000	-839,000	-351,000	192,000	373,000												-66,000	63,000	22,000	126,000	28,000	-30,000	76,000	14,000	-7,000	-16,000	15,000	17,000	23,000
net increase in cash and cash equivalents																																-11,899,000	-4,734,000	-6,620,000	13,029,000	1,500,000	-317,000	-51,688,000	5,649,000	4,079,000	5,097,000	11,095,000	12,053,000	24,676,000			-9,997,000	-274,000	2,310,000	-20,221,000	5,138,000	-89,819,000	17,239,000	9,287,000	-3,513,000	-1,884,000	10,848,000								438,000	26,543,000	85,401,000				6,027,000	46,762,000	192,359,000	7,527,000			-11,835,000	72,060,000	-7,084,000
cash and cash equivalents, beginning of year																																											113,940,000				59,196,000	0
cash and cash equivalents, end of year
provision (recovery) of doubtful accounts receivable
loss on sale of long-lived assets																																			22,000
non-cash restructuring																																				0	0			0	0	0	500,000	0	0	0	600,000	0	0	0	2,743,000	0										0	0	366,000
cash and cash equivalents, beginning of period																																	0	0	101,408,000		0	0	146,264,000		0				0					0	72,243,000		0	0	139,049,000		0	0	121,207,000	0	122,043,000	0	0	337,926,000
cash and cash equivalents, end of period																																	-4,734,000	-6,620,000	114,437,000		-317,000	-51,688,000	151,913,000		5,097,000	11,095,000	125,993,000			20,660,000	49,199,000		2,310,000	-20,221,000	77,381,000		17,239,000	9,287,000	135,536,000		10,848,000	13,943,000	116,142,000	-3,902,000	92,978,000	-33,186,000	-7,749,000	190,855,000
(gain) loss on sale of long-lived assets
payments of term loan debt issuance costs																																				0	0
amortization of discount on investments																																								-9,000			-1,000	9,000	31,000	51,000	117,000	156,000	162,000	131,000	14,000
benefit from doubtful accounts receivable																																																														109,000	-314,000	5,245,000
(gain) loss on disposal and write-off of long-lived assets
foreign currency transaction (gains) losses																																								-84,000						-4,000	-174,000				131,000	126,000	0	609,000	532,000
proceeds from sale of intellectual property and property, plant and equipment
payments made on capital leases																																												0	0	-140,000	-131,000	-130,000	-142,000	-114,000	-217,000
gain on sale of long-lived assets																																					149,000
formfactor, inc.condensed consolidated statements of cash flows
fair value of stock issued in connection with the acquisition of cascade microtech
fair value of stock options and restricted stock-based awards assumed in connection with acquisition of cascade microtech
fair value of vested stock options and restricted stock-based awards paid in cash in connection with the acquisition of cascade microtech
changes in accounts payable and accrued liabilities related to property, plant and equipment purchases																																							1,166,000	623,000	-304,000	-736,000	778,000								-33,000	1,502,000	496,000	273,000	-56,000
income and property taxes paid (refunded)																																							22,000
supplemental cash flow disclosures:
provision (recovery) for doubtful accounts receivable																																												0	0	-4,000	5,000
loss on sale of subsidiary																																																0	0
proceeds (use of cash) from sale of subsidiary																																												30,000	31,000
proceeds from sale of marketable securities																																																	0
(recovery) benefit from doubtful accounts receivable
(gain) loss on disposal, write-off and sale of long-lived assets
proceeds from sale of intellectual property and plant and equipment
income and property taxes (refunded) paid																																									725,000
loss on disposal and write-off of long-lived assets																																													39,000			11,000	36,000	170,000	148,000
deferred income taxes																																											6,000
income and property taxes refunded																																											-945,000
gain on settlement of litigation
acquisition of microprobe, net of cash acquired
fair value of stock issued in connection with the microprobe acquisition
working capital adjustment
net decrease in cash and cash equivalents
use of cash from sale of subsidiary																																																28,000	28,000
proceeds from sales of property, plant and equipment																																																								0	0	18,000	15,000
proceeds from sales of marketable securities																																																														12,293,000	16,150,000	2,755,000
proceeds from issuances of common stock, net of issuance costs																																																	1,281,000	106,000	1,220,000		1,074,000	-3,000	1,182,000
changes in operating assets and liabilities:
benefit from (recovery of) doubtful accounts receivable																																																			-3,000	22,000	0	0	30,000
income taxes paid																																																			-912,000							-424,000	1,687,000
amortization of investments																																																						16,000	51,000	84,000	142,000	144,000	99,000
write-down for excess and obsolete inventories
gain on release of secured borrowing
fair value of stock issued in connection with the acquisition of microprobe
income taxes paid (refunded)																																																				801,000	2,000	-942,000	99,000	152,000					-25,820,000	585,000	815,000	-27,391,000
amortization of discount (premium) on investments
gain on disposal and write-off of long-lived assets																																																					3,000	0	32,000
excess tax benefits from equity based compensation plans																																																														71,000	422,000	15,000	139,000	101,000	26,000	2,016,000	341,000	5,129,000	6,889,000	3,256,000	3,303,000
prepaids and other current assets																																																														-2,371,000	3,288,000	2,570,000
payments made in connection with acquisition of assets
proceeds from secured borrowing
non-cash investing activities:
gain on disposal of long-lived assets
deferred rent																																																																				382,000	59,000	43,000				258,000	645,000	-20,000	237,000
proceeds from issuances of common stock and awards, net of issuance costs																																																									1,936,000	42,000	1,534,000
changes in accounts payable and accrued liabilities related to property and equipment purchases																																																									214,000	247,000	-653,000
amortization (accretion) of investments
loss on disposal and impairment of property and equipment																																																																	0	143,000	839,000
foreign currency transaction (gains) / losses																																																												94,000	332,000
acquisition of property and equipment																																																																										-7,043,000	-9,155,000	-9,542,000	-2,578,000	-14,320,000	-6,633,000	-15,214,000	-1,560,000	-3,352,000	-3,689,000
proceeds from issuances of common stock and awards																																																												-14,000	1,550,000	4,554,000
purchases of property and equipment through accounts payable and accruals																																																												741,000	285,000	168,000	-2,932,000	-2,133,000
income taxes refunded
loss on disposal of property and equipment																																																													175,000	599,000	0	144,000							348,000			0
release of restricted cash
advance payment for acquisition of assets
net cash from (used) in investing activities
deferred revenue
purchase of marketable securities																																																																										-94,793,000	-82,495,000	-25,398,000	-21,242,000		-61,797,000
proceeds from issuance of common stock																																																																	2,225,000	200,000	3,253,000	12,794,000	3,765,000	16,347,000		2,837,000	187,989,000	1,829,000	6,100,000	1,377,000	3,085,000	5,883,000	3,210,000	727,000	4,013,000	56,644,000	199,000
cash and cash equivalents, beginning of the period																																																																	0	0	315,232,000	0	0	284,131,000	0	0	31,217,000		0	0	34,836,000		0	0	116,305,000		0
cash and cash equivalents, end of the period																																																																	438,000	26,543,000	400,633,000	-3,219,000	8,828,000	277,782,000	6,027,000	46,762,000	223,576,000		4,803,000	-4,114,000	23,001,000		-7,084,000	-25,922,000	99,232,000		-20,053,000
supplemental disclosure of significant non-cash investing activities:
purchases of property and equipment through accounts payable and accrued liabilities																																																																	-2,247,000	-1,210,000	-7,943,000	6,988,000	-1,471,000	1,613,000		-344,000	2,212,000			-1,826,000	4,798,000				6,700,000
deferred revenues and customer advances																																																																		2,134,000	132,000			1,213,000	1,058,000	936,000	974,000		1,149,000	202,000	-168,000
loss on disposal of equipment																																																																				293,000	88,000	195,000
increase in allowance for doubtful accounts																																																																											-44,000
tax benefit from employee stock option plans																																																																											2,403,000	1,293,000	683,000		642,000
proceeds from sales and maturities of marketable securities
acquisition of intangible research and development asset
change in accounts payable and accrued liabilities for purchase of property and equipment
tax benefits from employee stock option plans
interest income from stockholders’ notes receivable
restricted cash																																																																														0				0	-2,550,000
repayment of notes receivable from stockholders																																																																														0	0	0	661,000	728,000
repurchase of common stock																																																																																		0	0
proceeds from issuance of bank line of credit																																																																																		0	0
repayment of notes payable																																																																																		0
repayment of bank line of credit																																																																																		0
non-cash financing activities:
repurchase of common stock in connection with cancellation of notes receivable from stockholders
conversion of redeemable convertible preferred stock and warrants to common stock
deferred stock-based compensation
interest paid
deferred tax benefit
prepaid expenses and other assets																																																																											-3,131,000
acquisition of intangible asset																																																																											0	0	-400,000
purchases of property and equipment through accounts payable																																																																														-1,535,000	3,904,000
deferred tax provision
reduction in allowance for doubtful accounts																																																																															0
prepaid and other current assets																																																																															-1,318,000
repayment of notes payable and bank line of credit
deferred tax assets
proceeds from issuance of redeemable convertible preferred stock
proceeds from issuance of notes payable
common stock issued for notes receivable
purchase of investments
proceeds from maturities of investments
proceeds from payment of notes receivable from stockholders

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.